ANI Pharmaceuticals, Inc. Income Statement
ANIP / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
ANI Pharmaceuticals, Inc. reported $883M in revenue and $78M in net income for FY2025. Revenue has grown at a 72.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $883.4M | $614.4M | $486.8M | $316.4M | $216.1M | $208.5M | $52.9M | $201.6M | $176.8M | $128.6M | $30.1M | $56.0M | $20.4M | $20.4M | $435.2K |
| Cost of Revenue | - | - | - | - | - | $87.2M | $63.2M | $73.0M | $79.0M | $48.8M | $10.0M | $11.5M | $9.2M | $9.2M | - |
| SG&A Expense | $317.7M | $249.6M | $161.7M | $124.0M | $84.3M | $65.0M | $55.8M | $44.1M | $31.6M | $27.8M | $16.4M | $17.9M | $9.5M | $9.5M | $7.0M |
| R&D Expense | $51.7M | $44.6M | $34.3M | $22.3M | $11.4M | $16.0M | $19.8M | $15.4M | $9.1M | $2.9M | $1.7M | $2.7M | $1.2M | $1.2M | $44.2M |
| Operating Income | $111.1M | $584.0K | $47.0M | -$35.3M | -$39.8M | -$16.0M | $16.4M | $35.4M | $28.3M | $20.1M | $898.0K | $20.0M | -$42.0K | -$42.0K | - |
| Interest Expense | $32.6M | $33.6M | $35.6M | $28.5M | $11.9M | $9.5M | $13.5M | $14.9M | $11.3M | $11.3M | $811.0K | $811.0K | $1.3M | $1.3M | $681.6K |
| Income Tax | $17.5M | -$3.7M | $1.1M | -$14.8M | -$13.5M | -$3.4M | -$2.9M | $4.6M | $17.4M | $4.7M | $20.0K | -$9.4M | -$36.0K | -$36.0K | - |
| Net Income | $78.3M | -$18.5M | $18.8M | -$47.9M | -$42.6M | -$22.5M | $6.1M | $15.5M | -$1.1M | $3.9M | $301.0K | $28.7M | -$1.5M | -$1.5M | - |
| EPS (Basic) | $0.86 | -$3.05 | $0.86 | -$3.05 | -$3.40 | -$1.88 | -$0.09 | $1.31 | $1.34 | $0.34 | -$0.92 | -$0.92 | - | -$4.21 | -$1.40 |
| EPS (Diluted) | $0.85 | -$3.05 | $0.85 | -$3.05 | -$3.40 | -$1.88 | -$0.09 | $1.30 | $1.32 | $0.34 | -$0.92 | -$0.92 | $0.00 | -$4.21 | -$1.40 |
| Shares Outstanding | 21.1M | 16.3M | 18.2M | 16.3M | 12.6M | 12.0M | 11.5M | 11.8M | 11.6M | 11.6M | 5.1K | 5.1M | 0 | 11.0M | 5.7M |
| Operating Margin | 12.6% | 0.1% | 9.7% | -11.2% | -18.4% | -7.7% | 30.9% | 17.5% | 16.0% | 15.6% | 3.0% | 35.7% | -0.2% | -0.2% | - |
| Profit Margin | 8.9% | -3.0% | 3.9% | -15.1% | -19.7% | -10.8% | 11.5% | 7.7% | -0.6% | 3.1% | 1.0% | 51.4% | -7.4% | -7.4% | - |